Brimonidine Tartrate
ATC — · 4 markets · 29 records
HK 11 records · 1 strengths
Records without a stated strength · 1 ALPHAGAN P OPHTHALMIC SOLN 0.15%、APO-BRIMONIDINE OPHTHALMIC SOLUTION 0.2%、APO-BRIMONIDINE P OPHTHALMIC SOLUTION 0.15%、BRIMO EYE DROPS 0.2% W/V、BRIMOGAN EYE DROPS 0.2% W/V、BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2%、BRITIMO EYE DROPS 2MG/ML + 5MG/ML、COMBIGAN EYE DROPS +3
AU 9 records · 5 strengths
- 2 mg/mLliquidALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottleCOMBIGAN brimonidine tartrate 2.0mg/mL and timolol 5.0mg/mL eye drops bottle、ENIDIN brimonidine tartrate 2mg/mL eye drop bottle、SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle
- 1.5 mg/mLliquidALPHAGAN P 1.5 brimonidine tartrate 0.15% eye drop bottleENIDIN P 1.5 brimonidine tartrate 0.15% eye drop bottle
- 1 mg/mLliquidALPHAGAN P 1.0 brimonidine tartrate 1 mg/mL eye drop bottle
- 0.25 mg/mLliquidLUMIFY brimonidine tartrate 0.025% w/v eye drops solution bottle
- 5 mg/gtopicalMIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube
SG 8 records · 5 strengths
- 2 mg/mLliquidCOMBIGANSIMBRINZA EYE DROPS, SUSPENSION 10 MG/ML + 2 MG/ML
- 1 mg/mLliquidGLAALPHA combination ophthalmic solution
- 0.2 %liquidALPHAGAN OPHTHALMIC SOLUTION 0.2%
- 3.3 mg/gtopicalMirvaso 3mg/g gel
Records without a stated strength · 1 ALPHAGAN P OPHTHALMIC SOLUTION 0.1% w/v、ALPHAGAN P OPHTHALMIC SOLUTION 0.15% w/v、RIMONAL EYE DROPS 0.15% w/v
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 SIMBRINZA
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.